Monday, May 2, 2011

April Breast Cancer News for Patients

Last week, highlighted April news for women who completed breast cancer treatment. Today, we'll look at recent breast cancer news for current patients.

Let's start with breast cancer drugs. For those taking aromatase inhibitors, Bloomberg Business Week ran a story about the launch of a generic version of Femara (letrozole). There's been a lot of activity on our Halaven (eribulin) news page. In March, the National Comprehensive Cancer Network (NCCN) added Halaven to its guidelines as a preferred single agent option for metastatic disease. In April, Halaven made its international debut in the UK, Japan, Norway, Sweden and Denmark.

Breast cancer side effects are always a concern. For those considering a double mastectomy, US News and World Report covered a story about patient satisfaction twenty years later. For women who have breast cancer while pregnant, The Huffington Post addressed the safety of diagnostic mammography, surgery and chemotherapy during pregnancy.

I really like news about taking care of yourself while receiving breast cancer treatment. This month, The Los Angeles Times provided beauty tips for women undergoing chemotherapy. The story can be found on our Adriamycin (doxorubicin) news page. Also, FOX News revealed the four types of exercise that help patients most.

I look forward to continuing to cover news for breast cancer patients. As always, I welcome feedback about topics that interest you most. I'll keep you posted.

No comments:

Post a Comment